CD38 and leukemia: Next, western blotting analysis was revealed that PTL decreased the levels of caspase 3 and increased the levels of activated caspase 3 and PARP in differentiated leukemia cells (CD34-CD38+) and LSCK562/ADM (CD34+CD38-).